# The Heart Failure Diuresis Efficacy Comparison (DEA-HF) Study

> **NCT05904808** · PHASE4 · COMPLETED · sponsor: **Rambam Health Care Campus** · enrollment: 42 (actual)

## Conditions studied

- Chronic Heart Failure
- Diuretics Drug Reactions
- Congestive Heart Failure

## Interventions

- **DRUG:** IV Furosemide
- **DRUG:** IV Furosemide and PO Metolazone
- **DRUG:** IV Furosemide and IV Acetazolamide

## Key facts

- **NCT ID:** NCT05904808
- **Lead sponsor:** Rambam Health Care Campus
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-19
- **Primary completion:** 2023-08-01
- **Final completion:** 2023-08-24
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2024-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05904808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05904808, "The Heart Failure Diuresis Efficacy Comparison (DEA-HF) Study". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05904808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*